Funding · Company
Kriya Therapeutics, Inc.
Palo Alto, CABiotech & Pharma
Kriya Therapeutics, Inc. of Palo Alto, CA has disclosed $783M across 3 Form D offerings filed with the SEC between Jul 14, 2021 and Sep 10, 2025.
$783M
Total disclosed
3
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$321M
Form D · Sep 10, 2025 ↗
Q3 2025
· 1 amendment, first filed Aug 15, 2025
$362M
Form D · Jul 27, 2023 ↗
Q3 2023
· 1 amendment, first filed May 24, 2022
· target $432M
Filing details
HeadquartersPalo Alto, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001811209Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →